SCHEMBL3670712

SCHEMBL3670712

CCOC(=O)CC(=O)Nc1cc(C2=NOC(c3cc(Cl)cc(Cl)c3)(C(F)(F)F)C2)ccc1C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.40
HPGD P15428 1/20 0.40
KMT2A Q03164 1/20 0.40
LMNA P02545 3/20 0.36
ALDH1A1 P00352 3/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
TSHR P16473 1/20 0.36
HTT P42858 1/20 0.36
NLRP3 Q96P20 1/20 0.35
PKM P14618 1/20 0.35
RXFP1 Q9HBX9 1/20 0.35
HSD17B10 Q99714 1/20 0.35
F10 P00742 1/20 0.34
GAA P10253 2/20 0.34
POLB P06746 1/20 0.34
TP53 P04637 1/20 0.34
KDM4E B2RXH2 1/20 0.34
XBP1 P17861 1/20 0.34
MAPK1 P28482 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1547516 0.91 NLRP3 (0.37) HPGDLMNAALDH1A1SMN1; SMN2TSHR
SCHEMBL1547912 0.90 TP53 (0.40) MEN1KMT2ALMNAALDH1A1SMN1; SMN2
SCHEMBL1547945 0.89 POLB (0.47) MEN1HPGDKMT2ALMNAALDH1A1
SCHEMBL13319082 0.89 POLB (0.38) MEN1HPGDKMT2ALMNAALDH1A1
SCHEMBL1679640 0.88 LMNA (0.48) HPGDLMNAALDH1A1SMN1; SMN2TSHR
SCHEMBL1575938 0.88 LMNA (0.42) HPGDLMNAALDH1A1SMN1; SMN2TSHR
SCHEMBL1547592 0.87 KDM4E (0.42) HPGDLMNAALDH1A1SMN1; SMN2TSHR
SCHEMBL13299405 0.87 SMN1; SMN2 (0.36) HPGDLMNAALDH1A1SMN1; SMN2TSHR
SCHEMBL1547926 0.87 LMNA (0.39) MEN1HPGDKMT2ALMNAALDH1A1
SCHEMBL1547825 0.87 POLB (0.38) MEN1HPGDKMT2ALMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100137372-A1 ISOXAZOLINE COMPOUNDS AND THEIR USE IN PEST CONTROL SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-06-03 US disclosed
US-20100137372-A1 ISOXAZOLINE COMPOUNDS AND THEIR USE IN PEST CONTROL SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-06-03 US disclosed
EP-2139874-A2 ISOXAZOLINE COMPOUNDS AND THEIR USE IN PEST CONTROL Sumitomo Chemical Company, Limited (JP) 2010-01-06 EP disclosed
WO-2008126665-A2 ISOXAZOLINE COMPOUNDS AND THEIR USE IN PEST CONTROL SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2008-10-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100137372-A1 ISOXAZOLINE COMPOUNDS AND THEIR USE IN PEST CONTROL CYP4X1, PRDX5, PRDX1 MEN1 4632/4885HPGD 2814/4885KMT2A 1005/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.